Date: December 13, 2018
Time: 12:00 p.m. - 1:00 p.m.
Location: JW Marriott, 1331 Pennsylvania Ave NW, Washington, DC 20004
Nixon Peabody partner Hannah Bornstein will be a co-presenter on the topic “False Claims Act Enforcement, Policy Updates, and Trends in Patient Support,” at FDLI's annual Enforcement, Litigation, and Compliance Conference in Washington, DC. This panel will consider recent key cases and updates, including in the materiality standard, and whether companies can expect more FCA cases after Escobar. There has also been explosive attention in recent FCA enforcement surrounding reimbursement support activities by pharmaceutical manufacturers – panelists will discuss the unique risks associated with such activities, including best practices and compliance considerations for planning, implementing, and executing compliant reimbursement support activities and programs.
The annual Enforcement, Litigation, and Compliance Conference brings together industry, regulators, attorneys, litigators, academics, and consultants to discuss trends and issues in enforcement and compliance, the latest developments in both civil and criminal litigation, and recent cases and settlements. This conference offers an opportunity to hear from and interact with top officials from FDA, DOJ, FTC, and other government agencies.
The conference includes a keynote address by FDA commissioner Scott Gottlieb on December 12.
To learn more or to register, visit the FDLI (Food and Drug Law Institute) Enforcement, Litigation, and Compliance Conference website.